Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joren Callaert

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
The Journal of Cardiovascular Surgery|December 10, 2024
Two-year outcome of the paclitaxel-eluting Legflow balloon catheter in the treatment of long and complex femoropopliteal lesionsMarc Bosiers, Koen Deloose, Giovanni Torsello, et al.
The Journal of Cardiovascular Surgery|April 4, 2020
One-year outcome of the paclitaxel-eluting Legflow balloon catheter in the treatment of long and complex femoropopliteal lesionsMarc Bosiers, Koen Deloose, Giovanni Torsello, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|March 17, 2015
Superiority of stent-grafts for in-stent restenosis in the superficial femoral artery: twelve-month results from a multicenter randomized trialMarc Bosiers, Koen Deloose, Joren Callaert, et al.
The Journal of Cardiovascular Surgery|November 24, 2020
Stent-grafts are the best way to treat complex in-stent restenosis lesions in the superficial femoral artery: 24-month results from a multicenter randomized trialMarc Bosiers, Koen Deloose, Joren Callaert, et al.
The Journal of Cardiovascular Surgery|December 23, 2025
Head-to-head comparison of two paclitaxel-coated balloons for femoropopliteal lesions: 3-year results from the BIOPACT RCTMaxim Peeters, Joren Callaert, Wouter Lansink, et al.
JACC. Cardiovascular Interventions|December 13, 2023
Head-to-Head Comparison of 2 Paclitaxel-Coated Balloons for Femoropopliteal LesionsKoen R Deloose, Wouter Lansink, Marianne Brodmann, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|January 31, 2020
ZILVERPASS Study: ZILVER PTX Stent vs Bypass Surgery in Femoropopliteal LesionsMarc Bosiers, Carlo Setacci, Gianmarco De Donato, et al.
Cardiovascular and Interventional Radiology|September 5, 2023
ZILVERPASS Study: ZILVER PTX Stent versus Prosthetic Above-the-Knee Bypass Surgery in Femoropopliteal Lesions, 5-year ResultsMichel J Bosiers, Gianmarco De Donato, Giovanni Torsello, et al.
The Journal of Cardiovascular Surgery|May 10, 2023
ZILVERPASS Study: ZILVER PTX Stent vs. Bypass Surgery in Femoropopliteal Lesions, 3 year results and economic analysisMarc Bosiers, Gianmarco DE Donato, Giovanni Torsello, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
The Journal of Cardiovascular Surgery|December 10, 2024
Two-year outcome of the paclitaxel-eluting Legflow balloon catheter in the treatment of long and complex femoropopliteal lesionsMarc Bosiers, Koen Deloose, Giovanni Torsello, et al.
The Journal of Cardiovascular Surgery|April 4, 2020
One-year outcome of the paclitaxel-eluting Legflow balloon catheter in the treatment of long and complex femoropopliteal lesionsMarc Bosiers, Koen Deloose, Giovanni Torsello, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|March 17, 2015
Superiority of stent-grafts for in-stent restenosis in the superficial femoral artery: twelve-month results from a multicenter randomized trialMarc Bosiers, Koen Deloose, Joren Callaert, et al.
The Journal of Cardiovascular Surgery|November 24, 2020
Stent-grafts are the best way to treat complex in-stent restenosis lesions in the superficial femoral artery: 24-month results from a multicenter randomized trialMarc Bosiers, Koen Deloose, Joren Callaert, et al.
The Journal of Cardiovascular Surgery|December 23, 2025
Head-to-head comparison of two paclitaxel-coated balloons for femoropopliteal lesions: 3-year results from the BIOPACT RCTMaxim Peeters, Joren Callaert, Wouter Lansink, et al.
JACC. Cardiovascular Interventions|December 13, 2023
Head-to-Head Comparison of 2 Paclitaxel-Coated Balloons for Femoropopliteal LesionsKoen R Deloose, Wouter Lansink, Marianne Brodmann, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|January 31, 2020
ZILVERPASS Study: ZILVER PTX Stent vs Bypass Surgery in Femoropopliteal LesionsMarc Bosiers, Carlo Setacci, Gianmarco De Donato, et al.
Cardiovascular and Interventional Radiology|September 5, 2023
ZILVERPASS Study: ZILVER PTX Stent versus Prosthetic Above-the-Knee Bypass Surgery in Femoropopliteal Lesions, 5-year ResultsMichel J Bosiers, Gianmarco De Donato, Giovanni Torsello, et al.
The Journal of Cardiovascular Surgery|May 10, 2023
ZILVERPASS Study: ZILVER PTX Stent vs. Bypass Surgery in Femoropopliteal Lesions, 3 year results and economic analysisMarc Bosiers, Gianmarco DE Donato, Giovanni Torsello, et al.
Pageof 3